NCT06850623 - Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 19, 2025

Primary Completion Date

December 15, 2026

Study Completion Date

July 15, 2027

Conditions

Locally Advanced Pancreatic Adenocarcinoma

Interventions

COMBINATION_PRODUCT

Acoustic Cluster Therapy

Drug: PS101; Device: Ultrasound

DRUG

Modified FOLFIRINOX

Chemotherapy

Trial Locations (4)

RECRUITING

Allegheny General Hospital, Pittsburgh

RECRUITING

Henry Ford Centre, Detroit

RECRUITING

HonorHealth Research Institute, Scottsdale

RECRUITING

Brown University Cancer Institute, Providence